Showing results (821-830 of 2,733) with videos related to

Sort By:
Pageof 274
Pharmacogenomics|August 20, 2021
Pilot study of multi-gene pharmacogenetic testing for pain management in oncology palliative medicineJai N Patel, Danielle Boselli, James Symanowski, et al.
Pharmacogenomics|August 23, 2021
Systematic review of Pharmacogenomics Knowledgebase evidence for pharmacogenomic links to the dopamine reward pathway for heroin dependenceMaggie L McCorkle, David F Kisor, Caroline E Freiermuth, et al.
Pharmacogenomics|May 25, 2021
Inaugural Pharmacogenomics Access and Reimbursement SymposiumSara L Rogers, George P Patrinos, Christina Mitropoulou, et al.
Pharmacogenomics|May 25, 2021
The need for a refined understanding of CYP2D6 in second-generation antipsychotic outcomes in children and adolescentsKatelyn M Rossow, Samuel E Vaughn, Jeffrey R Strawn, et al.
Pharmacogenomics|May 8, 2015
Eradication of T315I mutation in chronic myeloid leukemia without third-generation tyrosine kinase inhibitor: a case reportGeoffroy Venton, Julien Colle, Cedric Mercier, et al.
Pharmacogenomics|May 20, 2020
Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapyWenyi Zhao, Jingcheng Wu, Shuqing Chen, et al.
Pharmacogenomics|May 7, 2020
HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI ConsortiumVincent Gagné, Pascal St-Onge, Patrick Beaulieu, et al.
Pharmacogenomics|April 29, 2020
Aggressive prostate cancer phenotype and genome-wide association studies: where are we now?Ana R Pinto, Jani Silva, Ricardo Pinto, et al.
Pharmacogenomics|June 16, 2020
Involvement of CYP2D6 and CYP2B6 on tramadol pharmacokineticsMiriam Saiz-Rodríguez, Dolores Ochoa, Manuel Román, et al.
Pharmacogenomics|September 16, 2021
UGT1A1 regulatory variant with potential effect on efficacy of HIV and cancer drugs commonly prescribed in South AfricaJenny Mary Mathew, Phelelani Thokozani Mpangase, Dhriti Sengupta, et al.
Pageof 274